Awaysis Capital, Inc. Files 2024 10-K

Ticker: AWCA · Form: 10-K · Filed: Oct 11, 2024 · CIK: 1021917

Awaysis Capital, Inc. 10-K Filing Summary
FieldDetail
CompanyAwaysis Capital, Inc. (AWCA)
Form Type10-K
Filed DateOct 11, 2024
Risk Levellow
Pages15
Reading Time18 min
Key Dollar Amounts$0.01, $7,093,476, $4,295,446, $12,642,933, $5,549,457
Sentimentneutral

Sentiment: neutral

Topics: 10-K, real estate, annual report

TL;DR

Awaysis Capital filed its 2024 10-K. Financials and operations for non-residential building operator are detailed.

AI Summary

Awaysis Capital, Inc. filed its 10-K for the fiscal year ending June 30, 2024, reporting on its operations as an operator of nonresidential buildings. The company, formerly known as JV Group, Inc., ASPI, Inc., and ASPEON INC, is incorporated in Delaware and headquartered in Miramar, Florida. The filing details financial data and operational aspects for the period.

Why It Matters

This 10-K filing provides investors and stakeholders with a comprehensive overview of Awaysis Capital's financial performance and operational status for the fiscal year ending June 30, 2024.

Risk Assessment

Risk Level: low — The provided text is a standard 10-K filing header and does not contain specific financial performance details or forward-looking statements that would indicate a high risk.

Key Numbers

  • 0630 — Fiscal Year End (Indicates the end of the reporting period for the 10-K.)
  • 20241011 — Filing Date (The date the 10-K was officially submitted to the SEC.)

Key Players & Entities

  • Awaysis Capital, Inc. (company) — Filer of the 10-K
  • JV GROUP, INC. (company) — Former company name
  • ASPI, INC. (company) — Former company name
  • ASPEON INC (company) — Former company name
  • 2024-06-30 (date) — Fiscal year end

FAQ

What is the primary business of Awaysis Capital, Inc.?

Awaysis Capital, Inc. is an operator of nonresidential buildings, as indicated by its Standard Industrial Classification code [6512].

When did Awaysis Capital, Inc. file its 10-K report?

The 10-K report was filed on October 11, 2024.

What fiscal year does this 10-K filing cover?

This 10-K filing covers the fiscal year ending on June 30, 2024.

What were some of Awaysis Capital, Inc.'s previous names?

Awaysis Capital, Inc. was formerly known as JV GROUP, INC., ASPI, INC., and ASPEON INC.

Where is Awaysis Capital, Inc. headquartered?

Awaysis Capital, Inc. is headquartered in Miramar, Florida, with its business address at 3400 Lakeside Dr, Suite 100.

Filing Stats: 4,590 words · 18 min read · ~15 pages · Grade level 13.5 · Accepted 2024-10-11 17:19:37

Key Financial Figures

  • $0.01 — (g) of the Act: Common Stock, par value $0.01 Indicate by check mark if the registr
  • $7,093,476 — ain profitability. We had a net loss of $7,093,476 and $4,295,446 for the fiscal years end
  • $4,295,446 — ty. We had a net loss of $7,093,476 and $4,295,446 for the fiscal years ended June 30, 202
  • $12,642,933 — 2023, we had an accumulated deficit of $12,642,933 and $5,549,457, respectively. We are
  • $5,549,457 — accumulated deficit of $12,642,933 and $5,549,457, respectively. We are dependent on ma
  • $11.4 million — greements was at the appraisal value of $11.4 million (excluding transaction costs and fees)
  • $2.6 million — ination of a Purchase Money Mortgage of $2.6 million at 0% interest rate, payable on demand,
  • $280,000 — on demand, a Purchase Money Mortgage of $280,000 at 0% interest rate that was paid on Au
  • $0.150 — arket price on the date of appraisal of $0.150. As the first acquisition by the Compan
  • $500,000 — horne"), for aggregate consideration of $500,000, or approximately $0.0051 per share. Th
  • $0.0051 — ideration of $500,000, or approximately $0.0051 per share. This transaction was deemed

Filing Documents

Risk Factors

Item 1A. Risk Factors 10

Unresolved Staff Comments

Item 1B. Unresolved Staff Comments 17

Cybersecurity

Item 1C. Cybersecurity 17

Properties

Item 2. Properties 17

Legal Proceedings

Item 3. Legal Proceedings 17

Mine Safety Disclosures

Item 4. Mine Safety Disclosures 17 PART II

Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 20

[Reserved]

Item 6. [Reserved] 19

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations 19

Quantitative and Qualitative Disclosures about Market Risk

Item 7A. Quantitative and Qualitative Disclosures about Market Risk 23

Financial Statements and Supplementary Data

Item 8. Financial Statements and Supplementary Data 23

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 23

Controls and Procedures

Item 9A. Controls and Procedures 23

Other Information

Item 9B. Other Information 24

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 24 PART III

Directors, Executive Officers and Corporate Governance

Item 10. Directors, Executive Officers and Corporate Governance 24

Executive Compensation

Item 11. Executive Compensation 28

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 32

Certain Relationships and Related Transactions, and Director Independence

Item 13. Certain Relationships and Related Transactions, and Director Independence 33

Principal Accountant Fees and Services

Item 14. Principal Accountant Fees and Services 34 PART IV

Exhibits and Financial Statement Schedules

Item 15. Exhibits and Financial Statement Schedules 35

Form 10-K Summary

Item 16. Form 10-K Summary 35 i NOTE REGARDING REFERENCES TO OUR COMPANY Throughout this Form 10-K, the words "we," "us," "our," the "Company" and "Awaysis" refer to Awaysis Capital, Inc., a Delaware corporation, and, unless the context otherwise requires, our directly and indirectly wholly owned subsidiaries. CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This Annual Report on Form 10-K contains forward-looking statements. Forward-looking statements convey management's expectations as to the future of Awaysis, and are based on management's beliefs, expectations, assumptions and such plans, estimates, projections and other information available to management at the time Awaysis makes such statements. Forward-looking statements include all statements that are not historical facts and may be identified by terminology such as the words "outlook," "believe," "expect," "potential," "goal," "continues," "may," "will," "should," "could,", "would", "seeks," "approximately," "projects," predicts," "intends," "plans," "estimates," "anticipates" "future," "guidance," "target," or the negative version of these words or other comparable words, although not all forward-looking statements may contain such words. The forward-looking statements contained in this Annual Report on Form 10-K may include statements related to Awaysis' revenues, earnings, taxes, cash flow and related financial and operating measures, and expectations with respect to future operating, financial and business performance, and other anticipated future events and expectations that are not historical facts. Awaysis cautions you that our forward-looking statements involve known and unknown risks, uncertainties and other factors, including those that are beyond Awaysis' control, which may cause the actual results, performance or achievements to be materially different from the future results. Factors that could cause Awaysis' actual results to differ materially from those contemplated by its f

View Full Filing

View this 10-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.